Koki Mizukami, Y. Sakata, K. Seo, Shinichiro Kitamoto, T. Mura, A. Kikkawa, Koichi Hiraki
{"title":"Pembrolizumab单药治疗非小细胞肺癌患者TPS发生免疫相关不良事件的多中心联合回顾性研究","authors":"Koki Mizukami, Y. Sakata, K. Seo, Shinichiro Kitamoto, T. Mura, A. Kikkawa, Koichi Hiraki","doi":"10.5649/jjphcs.47.239","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":14574,"journal":{"name":"Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)","volume":"2016 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-05-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Multicenter Joint Retrospective Study on the Onset of Immune-related Adverse Events by TPS in Patients Indicated for Non-small Cell Lung Cancer Pembrolizumab Monotherapy\",\"authors\":\"Koki Mizukami, Y. Sakata, K. Seo, Shinichiro Kitamoto, T. Mura, A. Kikkawa, Koichi Hiraki\",\"doi\":\"10.5649/jjphcs.47.239\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":14574,\"journal\":{\"name\":\"Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)\",\"volume\":\"2016 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-05-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5649/jjphcs.47.239\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5649/jjphcs.47.239","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Multicenter Joint Retrospective Study on the Onset of Immune-related Adverse Events by TPS in Patients Indicated for Non-small Cell Lung Cancer Pembrolizumab Monotherapy